5F-EDMB-PICA
5F-EDMB-PICA_structure.png | |
5F-EDMB-PICA is a synthetic cannabinoid that has been used as a designer drug. It is a potent agonist of the cannabinoid receptors, specifically the CB1 receptor.
Chemical Structure and Properties[edit | edit source]
5F-EDMB-PICA belongs to the indole-3-carboxamide family of synthetic cannabinoids. Its chemical structure is characterized by a 5-fluoropentyl chain attached to the indole core, with a methoxybenzyl group at the nitrogen atom of the indole. The presence of the fluorine atom in the pentyl chain is a common modification in synthetic cannabinoids, often used to increase potency and metabolic stability.
Pharmacology[edit | edit source]
5F-EDMB-PICA acts as a full agonist at the CB1 receptor, which is primarily responsible for the psychoactive effects of cannabinoids. The binding affinity and efficacy at the CB1 receptor are significant, leading to effects that mimic those of tetrahydrocannabinol (THC), the primary psychoactive component of cannabis.
Effects[edit | edit source]
The effects of 5F-EDMB-PICA are similar to those of other synthetic cannabinoids and can include:
- Euphoria
- Altered perception
- Relaxation
- Anxiety or paranoia
- Tachycardia
- Nausea
Toxicity[edit | edit source]
The use of 5F-EDMB-PICA has been associated with adverse effects, including severe toxicity and even fatalities. Symptoms of overdose may include severe agitation, seizures, and cardiovascular complications.
Legal Status[edit | edit source]
The legal status of 5F-EDMB-PICA varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use.
Synthesis[edit | edit source]
The synthesis of 5F-EDMB-PICA involves the reaction of 5-fluoropentylindole with 2-methoxybenzyl chloride in the presence of a base to form the carboxamide linkage. This synthetic route is similar to that of other indole-based synthetic cannabinoids.
Detection in Biological Samples[edit | edit source]
5F-EDMB-PICA can be detected in biological samples using techniques such as gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS). These methods are used in forensic and clinical toxicology to confirm exposure to the substance.
Also see[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD